RxDoctor Payments Data

Pooja Swamy, MD

Interventional Cardiology · South Miami, FLNPI 1356570626

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.6%), food and beverage and education — rather than concentrated in one kind of arrangement. Abiomed accounts for 73.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $3,362 and has fallen 98.6% since, to $46 in 2025. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.

$6,592in general payments, 2019–2025

Across 71 payments — averaging $92.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$5K
  • Abbott$730
  • Boston Scientific$259
  • Cardiovascular Systems Inc.$229
  • Medtronic$162
  • Philips North America LLC$130
  • plus $218 from 4 others
$52,566in research payments, 2019–2025

Across 16 payments — averaging $3285.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Shockwave Medical, Inc$52K
  • Abiomed$174

What the payments were for

  • Travel & lodging$3,66656%
  • Food & beverage$2,85743%
  • Education$691%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,592 in reported general payments places this provider in the 40th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Medicare billing

Part B allowed, 2024
$96,331
Medicare patients
608
Services billed
1,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan38$50,171
JardianceEmpagliflozin22$33,785
EliquisApixaban20$25,189
FarxigaDapagliflozin Propanediol17$18,132
Ranolazine ErRanolazine19$1,562
Atorvastatin Calcium149$1,228
Losartan Potassium90$913
Carvedilol119$787
ClopidogrelClopidogrel Bisulfate87$782
Metoprolol Succinate71$769
Nitroglycerin PatchNitroglycerin17$644
Amlodipine Besylate76$627
Spironolactone69$528
Ezetimibe40$514
Nitroglycerin24$385

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in South Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →